News

For all media enquiries email us at [email protected] or call 0478 854 644.

Mental illness or environmental adaption
A recent, popular Talking Point presentation by Dr Haley Peckham offers a complementary way of understanding the brain’s response to growing up in a harsh environment.
Staff-Profile-Rowan
Congratulations to Dr Rowan Ogeil, who has just been appointed to the Editorial Board of Drug and Alcohol Review as a Deputy Editor.
Victorian-gambling-reforms_image
Turning Point and MARC have made a joint submission to the Victorian consultation on the implementation of carded play and pre-commitment on poker machines across the state.
The Health4Her Project builds momentum
Health4Her is an evidence-based health promotion program that helps women attending breast screening services protect themselves from the harm caused by alcohol.
Zero alcohol drink risks in the spotlight
Better regulation and community education are needed to manage the risks associated with zero-alcohol drinks. 
Applications are now open for Honours, Master's and PhD research pathways starting in 2024 at Turning Point!
PhD Scholarships at $33,000 per annum are now available. We also welcome students across different levels and backgrounds, from Honours, Master’s and PhD students, to medical practitioners and clinicians undertaking research projects.
Dr_Shalini_Arunogiri_Profile
The prestigious Young Tall Poppy Science Awards are run by the Australian Institute of Policy and Science (AIPS) to honour up-and-coming scientists who combine world-class research with a passionate commitment to communicating science.
latest-aodstats-bulletin_image
The latest AODstats Bulletin has just been released with a focus on drug-related hospital admissions in the years 2020–21 and 2021–22.
peer-led-group-helps_image
A new paper has found that the BreakThrough peer-led group is an effective support for a family member who has a loved one experiencing addiction.
getting-ahead-fentanyl-threat_image
A new article by Monash Addiction Research Centre’s Deputy Director, Professor Suzanne Nielsen and Turning Point's Executive Clinical Director, Professor Dan Lubman AM, has been published in the Monash Lens, calling on Australia to act now to get ahead of the fentanyl threat.
drug-monitoring-program_image
The importance of drawing on up-to-date evidence to monitor the impact of policy change on prescribing practices has recently been highlighted in the findings from a team of researchers at Monash Addiction Research Centre.
An intake worker looks at a clipboard while talking to a client at a hospital reception desk
An article published this month in the Medical Journal of Australia by Turning Point’s addiction trainee registrar, Dr Richard Bradlow, has identified a risk that dihydrocodeine misuse may be missed in clinical practice due to a lack of knowledge.